Page last updated: 2024-10-24

neuropeptide receptor activity

Definition

Target type: molecularfunction

Combining with a neuropeptide to initiate a change in cell activity. [GOC:ai]

Neuropeptide receptor activity encompasses the intricate molecular processes by which cells receive and interpret signals transmitted by neuropeptides. These signaling molecules, produced by neurons, play pivotal roles in regulating diverse physiological functions across the nervous system and beyond. The activity involves a series of events initiated by the binding of a neuropeptide to its cognate receptor, a transmembrane protein embedded within the cell membrane. This binding event triggers conformational changes in the receptor, leading to the activation of downstream signaling pathways. These pathways can involve a cascade of intracellular events, including alterations in protein phosphorylation, changes in ion channel permeability, and modulation of gene expression. The specific molecular mechanisms underlying neuropeptide receptor activity vary depending on the receptor type and the signaling cascade involved. However, all neuropeptide receptors share the fundamental role of converting extracellular neuropeptide signals into intracellular responses that ultimately influence cellular function and behavior. This intricate molecular machinery underpins the diverse roles of neuropeptides in regulating processes such as neurotransmission, hormone release, pain perception, appetite, and stress responses.'
"

Proteins (13)

ProteinDefinitionTaxonomy
Neuromedin-U receptor 1A neuromedin-U receptor 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9HB89]Homo sapiens (human)
Bombesin receptor subtype-3A bombesin receptor subtype-3 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P32247]Homo sapiens (human)
Neuropeptide Y receptor type 1A neuropeptide Y receptor type 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P25929]Homo sapiens (human)
Neuromedin-B receptorA neuromedin-B receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:P28336]Homo sapiens (human)
Neuromedin-U receptor 2A neuromedin-U receptor 2 that is encoded in the genome of human. [PRO:CNx, Reactome:R-HSA-964816]Homo sapiens (human)
Neuropeptide FF receptor 2A neuropeptide FF receptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9Y5X5]Homo sapiens (human)
Neuropeptide FF receptor 1A neuropeptide FF receptor 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9GZQ6]Homo sapiens (human)
Melanin-concentrating hormone receptor 1A melanin-concentrating hormone receptor 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q99705]Homo sapiens (human)
KiSS-1 receptorA KiSS-1 receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q969F8]Homo sapiens (human)
Neuropeptide S receptorA neuropeptide S receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q6W5P4]Homo sapiens (human)
Neuropeptides B/W receptor type 1A neuropeptides B/W receptor type 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P48145]Homo sapiens (human)
Gastrin-releasing peptide receptorA gastrin-releasing peptide receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:P30550]Homo sapiens (human)
Orexin receptor type 2An orexin receptor type 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O43614]Homo sapiens (human)

Compounds (50)

CompoundDefinitionClassesRoles
benextraminebenextramine: RN given refers to parent cpd
omeprazole5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
aromatic ether;
benzimidazoles;
pyridines;
sulfoxide
synephrineethanolamines;
phenethylamine alkaloid;
phenols
alpha-adrenergic agonist;
plant metabolite
benzethonium chloridebenzethonium chloride : A (synthetic) quaternary ammonium salt that is benzyldimethylamine in which the nitrogen is quaternised by a 2-{2-[p-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy}ethyl group, with chloride as the counter-ion. An antiseptic and disinfectant, it is active against a broad spectrum of bacteria, fungi, moulds and viruses.aromatic ether;
chloride salt;
quaternary ammonium salt
antibacterial agent;
antifungal agent;
antiseptic drug;
antiviral agent;
disinfectant
omeprazole sulfideomeprazole sulfide: omeprazole metabolite; structure given in first sourcebenzimidazoles
harmalanharmalan: structure given in first sourceharmala alkaloid
1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine: RN given refers to parent cpd
1-methyl-6-methoxy-dihydro-beta-carboline
sb 408124SB 408124: a hypocretin receptor type 1 (HcrtR1) antagonistorganohalogen compound;
quinolines
rutinHydroxyethylrutoside: Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders.disaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone
antioxidant;
metabolite
harmineharmine : A harmala alkaloid in which the harman skeleton is methoxy-substituted at C-7.

Harmine: Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but (as banisterine) was hailed as a cure for postencephalitic PARKINSON DISEASE in the 1920's.
harmala alkaloidanti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
metabolite
bibp 3226BIBP 3226: a selective non-peptide neuropeptide Y Y1 receptor antagonist; structure given in first source; BIBP-3435 is the S-enantiomer
cgp 71683 anaphthalenes;
sulfonic acid derivative
sb 334867-a1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea: selective OX1 receptor antagonistnaphthyridine derivative
gw 803430
pd 176252PD 176252: a non-peptide gastrin-releasing peptide (BB2) receptor antagonist; structure in first source
phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide
t-226296T-226296: structure in first source
jnj 10397049JNJ 10397049: a selective orexin receptor-2 antagonist
n-(4-((4-(dimethylamino)quinazolin-2-yl)amino)cyclohexyl)-3,4-difluorobenzamide hydrochloride
pd 168368PD 168368: a neuromedin B receptor antagonist; structure in first source
4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride
bms 193885
fmrfamideFMRFamide: A molluscan neuroactive peptide which induces a fast excitatory depolarizing response due to direct activation of amiloride-sensitive SODIUM CHANNELS. (From Nature 1995; 378(6558): 730-3)
sb674042SB674042: nonpeptide antagonist to the human orexin-1 receptor; structure in first source
neuromedin u 8
tcs ox2 29
sha 68
snap7941SNAP7941: structure in first source
neuropeptide y (24-36) amide, n-acetyl-(leu(28,31))-neuropeptide Y (24-36) amide, N-acetyl-(Leu(28,31))-: a presynaptic (Y2) receptor-specific neuropeptide Y analog
neuropeptide yNeuropeptide Y: A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones.
bombesin
lu aa33810
almorexantalmorexant: a dual orexin receptor antagonist for treatment of insomniaisoquinolines
suvorexantsuvorexant : An aromatic amide obtained by formal condensation of the carboxy group of 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid with the secondary amino group of 5-chloro-2-[(5R)-5-methyl-1,4-diazepan-1-yl]-1,3-benzoxazole. An orexin receptor antagonist used for the management of insomnia.

suvorexant: an orexin receptor antagonist; structure in first source
1,3-benzoxazoles;
aromatic amide;
diazepine;
organochlorine compound;
triazoles
central nervous system depressant;
orexin receptor antagonist
mk-6096MK-6096: antagonist of orexin receptors 1 and 2; structure in first source
sb 649868N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide: antagonist of both orexin 1 and orexin 2 receptors; for treating insomnia; structure in first source
kisspeptin-10 protein, human
act-462206ACT-462206: an antagonist of both orexin 1 and oxexin 2 receptors; structure in first source
oroxin b
gsk 1059865
nitd 609NITD 609: an antimalarial and coccidiostat; structure in first source
5-chloro-2-(3,5-dimethylphenyl)-4-(4-methoxyphenoxy)-3-pyridazinonearomatic ether
tak-683TAK-683: has antineoplastic activity
AZD1979AZD1979 : A carboxamide resulting from the formal condensation of the carboxy group of 5-(p-methoxyphenyl)-1,3,4-oxadiazole-2-carboxylic acid with the amino group of 3-phenoxyazetidine and in which the phenoxy group has been substituted at the para- position by a 2-oxa-6-azaspiro[3.3]heptan-6-ylmethyl group. It is a melanin concentrating hormone receptor 1 (MCHr1) antagonist.

AZD1979: an antagonist of melanin concentrating hormone receptor 1; structure in first source
aromatic ether;
azaspiro compound;
carboxamide;
N-acylazetidine;
oxadiazole;
oxaspiro compound;
oxetanes
melanin-concentrating hormone receptor antagonist
mk 5046
inosine5-chloro-2-(9H-fluoren-9-yl)-4-(4-methoxyphenoxy)pyridazin-3(2H)-one: an NPBWR1 antagonist; structure in first source
RF9dipeptidekisspeptin receptor agonist;
neuropeptide FF receptor agonist;
neuropeptide FF receptor antagonist
act-335827
orexin-a